- Home
- NERV vs BSLK Comparison
NERV vs BSLK Comparison
Compare NERV & BSLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- BSLK
- Stock Information
- Founded
- NERV 2007
- BSLK 2009
- Country
- NERV United States
- BSLK United States
- Employees
- NERV N/A
- BSLK N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- BSLK
- Sector
- NERV Health Care
- BSLK
- Exchange
- NERV Nasdaq
- BSLK NYSE
- Market Cap
- NERV 16.0M
- BSLK 16.0M
- IPO Year
- NERV 2014
- BSLK N/A
- Fundamental
- Price
- NERV $2.23
- BSLK $0.39
- Analyst Decision
- NERV Hold
- BSLK
- Analyst Count
- NERV 1
- BSLK 0
- Target Price
- NERV $5.00
- BSLK N/A
- AVG Volume (30 Days)
- NERV 37.0K
- BSLK 1.6M
- Earning Date
- NERV 02-20-2025
- BSLK 02-21-2025
- Dividend Yield
- NERV N/A
- BSLK N/A
- EPS Growth
- NERV N/A
- BSLK N/A
- EPS
- NERV N/A
- BSLK N/A
- Revenue
- NERV N/A
- BSLK $1,489,000.00
- Revenue This Year
- NERV N/A
- BSLK N/A
- Revenue Next Year
- NERV N/A
- BSLK N/A
- P/E Ratio
- NERV N/A
- BSLK $0.08
- Revenue Growth
- NERV N/A
- BSLK N/A
- 52 Week Low
- NERV $2.06
- BSLK $0.23
- 52 Week High
- NERV $13.49
- BSLK $17.02
- Technical
- Relative Strength Index (RSI)
- NERV 50.40
- BSLK N/A
- Support Level
- NERV $2.07
- BSLK N/A
- Resistance Level
- NERV $2.39
- BSLK N/A
- Average True Range (ATR)
- NERV 0.12
- BSLK 0.00
- MACD
- NERV -0.01
- BSLK 0.00
- Stochastic Oscillator
- NERV 48.48
- BSLK 0.00
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About BSLK BOLT PROJECTS HOLDINGS INC
Bolt Projects Holdings Inc formerly Golden Arrow Merger Corp is an shell company.